1[1]Gaydos CA,Quinn TC ,Eiden JJ.Identification of Chlamydia pneumoniae by DNA amplification of the 16SrRNA gene[J]. J Clin Microbiol, 1992, 30:796-800
2[2]Ieven M,Ursi D, van Bever H, et al.Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M.pneumoniae in acute respiratory tract infections in pediatric patients[J]. J Infect Dis,1996, 173:1445-1452
3[3]Darelid J,Lofgren S,Malmvall BE,et al.Legionella pneumophila serogroup 1 antibody kinetics in patients with Legionnaires' disease:implications for serological diagnosis[J]. Scand J Infect Dis, 2003, 35:15-20
4[4]Jokinen C, Heiskanen L, Juvonen H,et al.Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland[J]. Clin Infect Dis, 2001, 32:1141-1154
5[5]Principi N, Esposito , Blasi F,et al.Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections[J]. Clin Infect Dis, 2001, 32:1281-1289
6[6]Gotfried MH.Epidemiology of clinically diagnosed community-acquired pneumonia in the primary care setting:results from the 1999-2000 respiratory surveillance program[J]. Am J Med,2001, 111(Suppl): 25S-29S
7[7]Dorigo-Zetsma JW,Zaat SA, Wertheim-van Dillen PM,et al.Comparison of PCR,culrure,and serological tests for diagnosis of Mycoplasma pneumoniae respireatory tract infection in children[J]. J Clin Microbiol,1999, 37:14-17
8Mandell L,Niederman M,The Canadian community-acquired pneumonia consensus conference.Antimicrobial treatment of community-acquired pneumonia in adults: a conference report[].Canadian Journal of Infectious Diseases.1993
9The ASCAP Panal Consense Report.Community-acquired pneumonia(CAP)year 2002 antibiotic selection and management update[].Hosp Med Consensus Rep.2002
10Niederman MS.Guidelines for the management of community-acquired pneumonia[].The Medical Clinics of North America.2001
